Compounds having both angiotensin II receptor antagonism and PPARy activating activities

Details for Australian Patent Application No. 2007343139 (hide)

Owner Pfizer Products Inc.

Inventors Schaum, Robert Philip; Casimiro-Garcia, Agustin; Bigge, Christopher Franklin; Risley, Hud Lawrence; Lee, Chitase

Agent Allens Arthur Robinson

Pub. Number AU-A-2007343139

PCT Pub. Number WO2008/084303

Priority 60/970,653 07.09.07 US; 60/876,334 21.12.06 US

Filing date 3 December 2007

Wipo publication date 17 July 2008

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

2 July 2009 PCT application entered the National Phase

  PCT publication WO2008/084303 Priority application(s): WO2008/084303

3 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007343153-Method for producing a water self dispersible metallic oxide and hydroxide powder, powder and aqueous dispersion thus obtained, and uses thereof

2007343135-Succinate salt of 2-((4-(1-methyl-4-(pyridin-4-yl)-1H-pyra zol-3-yl) phenoxy)methyl)quinoline